Tiapamil, a new calcium antagonist. 2. Further pharmacological characterization and toxicology.
D000700:Analgesics; D000758:Anesthesia; D000818:Animals; D000893:Anti-Inflammatory Agents; D001341:Autonomic Nervous System / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000633:toxicity; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D051379:Mice; D011437:Propylamines / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D013976:Tiapamil Hydrochloride; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D002121:Calcium Channel Blockers; D011437:Propylamines; D013976:Tiapamil Hydrochloride